Acasă › Cancer hepatic (carcinom hepatocelular) › Illinois › Chicago
Studii clinice pentru Cancer hepatic (carcinom hepatocelular) în Chicago, IL
16 studii pentru Cancer hepatic (carcinom hepatocelular) caută participanți în și în jurul orașului Chicago (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
În curs de recrutareFaza 1
- Exelixis Clinical Site #26, Chicago
National Liver Cancer Screening Trial
În curs de recrutareFaza 4
- Northwestern University, Chicago
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
În curs de recrutareFaza 1/2
- Local Institution - 0107, Chicago
Defining the Ablative Dose for Y-90 TARE
În curs de recrutareFaza 2
- Northwestern University, Chicago
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
În curs de recrutareStudiu observațional
- RUSH University Medical Center, Chicago
- University of Chicago, Chicago
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
În curs de recrutareFaza 3
- Research Site, Chicago
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
În curs de recrutareFaza 1/2
- Lurie Children's Hospital-Chicago, Chicago
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
În curs de recrutareFaza 3
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
În curs de recrutareFaza 2
- University of Chicago Comprehensive Cancer Center, Chicago
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
În curs de recrutareStudiu observațional
- Rush University Medical Center, Chicago
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
În curs de recrutareFaza 1/2
- Northwestern University, Chicago
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
În curs de recrutareFaza 1
- Clinical Trial Site, Chicago
Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
În curs de recrutareFaza 2
- Northwestern University, Chicago
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
În curs de recrutareFaza 4
- University of Chicago Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Chicago
The Dragon PLC Trial (DRAGON-PLC)
În curs de recrutare
- Rush University Medical Center, Chicago
Studii pentru Cancer hepatic (carcinom hepatocelular) în alte orașe
- Houston, TX31 studii
- New York City, NY24 studii
- Dallas, TX19 studii
- Los Angeles, CA19 studii
- Boston, MA18 studii
- Cleveland, OH18 studii
- Philadelphia, PA16 studii
- Pittsburgh, PA15 studii
- San Francisco, CA14 studii
- Orange, CA14 studii
- Jacksonville, FL14 studii
- San Antonio, TX13 studii
Alte studii în Chicago
- Cancer pulmonar cu celule non-pătrate61 studii
- Cancer de sân59 studii
- Cancer (toate tipurile)51 studii
- Cancer metastatic45 studii
- Cancer de prostată45 studii
- Cancer pulmonar41 studii
- Obezitate41 studii
- Cancer ovarian36 studii
- Cancer colorectal34 studii
- Accident vascular cerebral34 studii
- Insuficiență cardiacă31 studii
- Supraponderalitate29 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.